Researchers have presented data that supports the cancer fighting potential of growth hormone-releasing hormone technology developed by two Miller School of Medicine scientists. The work was featured in a September 5 presentation at the American Society of Clinical Oncology’s (ASCO) Breast Cancer Symposium 2014.
Renal Pathology ServiceMore info
39th REVIEW AND ADVANCES IN PATHOLOGYMore info
Among the Nation’s BestLearn More
Dedicated to Providing Quality Patient CareLearn More
Providing the Highest Quality EducationLearn More
Carolyn Cray, Ph.D., professor of clinical pathology and microbiology and immunology, was invited to speak at the closing session of the XVI Biennial Conference of the International Society of Animal Clinical Pathology in Copenhagen, Denmark.
The National Institutes of Health/National Cancer Institute has awarded researchers at the Miller School of Medicine $3 million in funding over five years to explore breakthrough uses of MRI imaging and genetic signatures in managing prostate cancer diagnosis and treatment.